Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Free Cash Flow (2022 - 2026)

GE HealthCare Technologies filings provide 5 years of Free Cash Flow readings, the most recent being $204.0 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 108.16% to $204.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $1.6 billion, a 1.53% decrease, with the full-year FY2025 number at $1.5 billion, down 16.94% from a year prior.
  • Free Cash Flow hit $204.0 million in Q1 2026 for GE HealthCare Technologies, down from $916.0 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $1.1 billion in Q4 2024 to a low of -$216.0 million in Q2 2023.
  • Median Free Cash Flow over the past 5 years was $368.0 million (2022), compared with a mean of $415.2 million.
  • Biggest five-year swings in Free Cash Flow: crashed 176.92% in 2023 and later soared 185.25% in 2025.
  • GE HealthCare Technologies' Free Cash Flow stood at $986.0 million in 2022, then fell by 3.04% to $956.0 million in 2023, then rose by 11.82% to $1.1 billion in 2024, then fell by 14.31% to $916.0 million in 2025, then tumbled by 77.73% to $204.0 million in 2026.
  • The last three reported values for Free Cash Flow were $204.0 million (Q1 2026), $916.0 million (Q4 2025), and $335.0 million (Q3 2025) per Business Quant data.